Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 25 09:32AM ET
154.53
Dollar change
-4.52
Percentage change
-2.84
%
IndexRUT P/E1738.26 EPS (ttm)0.09 Insider Own16.50% Shs Outstand28.24M Perf Week-5.76%
Market Cap4.37B Forward P/E28.74 EPS next Y5.38 Insider Trans-4.56% Shs Float23.62M Perf Month-11.28%
Income10.93M PEG- EPS next Q0.27 Inst Own84.81% Short Float10.37% Perf Quarter28.04%
Sales50.70M P/S86.23 EPS this Y509.90% Inst Trans0.26% Short Ratio6.15 Perf Half Y32.02%
Book/sh27.58 P/B5.60 EPS next Y126.07% ROA1.59% Short Interest2.45M Perf Year76.83%
Cash/sh18.81 P/C8.21 EPS next 5Y- ROE1.68% 52W Range82.09 - 189.97 Perf YTD24.56%
Dividend Est.- P/FCF- EPS past 5Y- ROI1.39% 52W High-18.65% Beta0.89
Dividend TTM- Quick Ratio17.55 Sales past 5Y0.00% Gross Margin84.02% 52W Low88.25% ATR (14)6.56
Dividend Ex-Date- Current Ratio17.76 EPS Y/Y TTM103.28% Oper. Margin-191.77% RSI (14)36.47 Volatility4.48% 3.62%
Employees229 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin21.56% Recom1.00 Target Price192.44
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q124.16% Payout0.00% Rel Volume0.17 Prev Close159.05
Sales Surprise47.60% EPS Surprise197.31% Sales Q/Q- EarningsFeb 26 BMO Avg Volume398.03K Price154.53
SMA20-10.27% SMA50-4.11% SMA20020.57% Trades Volume3,777 Change-2.84%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Initiated Goldman Buy $160
Oct-24-23Initiated Cantor Fitzgerald Overweight $100
Oct-12-23Initiated Citigroup Buy $160
Sep-07-23Initiated Berenberg Buy $154
Apr-18-23Initiated Stifel Buy $102
Feb-28-23Upgrade Goldman Neutral → Buy $79 → $124
Aug-25-22Downgrade Goldman Buy → Neutral $74
Jan-18-22Initiated BofA Securities Buy $110
Jul-20-21Upgrade Goldman Neutral → Buy $73 → $90
Sep-18-20Initiated B. Riley FBR Buy $100
Apr-23-24 09:35AM
Apr-22-24 07:00AM
Apr-17-24 08:50AM
Apr-04-24 07:00AM
Apr-01-24 08:50AM
07:44AM Loading…
Mar-27-24 07:44AM
Mar-26-24 07:00AM
Mar-14-24 08:50AM
Mar-08-24 12:20PM
12:00PM
12:00PM
Mar-02-24 12:00AM
Mar-01-24 07:31AM
Feb-28-24 11:07AM
07:00AM
08:50AM Loading…
Feb-27-24 08:50AM
Feb-26-24 11:28PM
09:25AM
08:31AM
08:00AM
Feb-20-24 07:00AM
Feb-13-24 07:00AM
Feb-08-24 07:00AM
Feb-01-24 07:00AM
Jan-24-24 11:01PM
Jan-04-24 07:00AM
Dec-20-23 12:00PM
Dec-19-23 07:00AM
Dec-10-23 11:59AM
Dec-07-23 07:03AM
09:55AM Loading…
Dec-05-23 09:55AM
Nov-27-23 07:00AM
Nov-21-23 08:21PM
Nov-10-23 06:55AM
Nov-09-23 07:00AM
Nov-07-23 10:26AM
03:22AM
Nov-06-23 08:03AM
07:00AM
Oct-30-23 03:46PM
07:00AM
Sep-28-23 07:00AM
Sep-21-23 09:00AM
Sep-13-23 05:01PM
Sep-07-23 07:00AM
Sep-05-23 07:00AM
Aug-22-23 11:56AM
Aug-21-23 11:04AM
07:00AM
Aug-08-23 06:23AM
Aug-07-23 07:00AM
Jul-26-23 06:07PM
04:14PM
Jul-21-23 08:15AM
Jul-17-23 08:50AM
Jul-10-23 04:01PM
Jul-03-23 07:00AM
Jun-28-23 08:30AM
Jun-05-23 07:00AM
06:44AM
Jun-03-23 08:30AM
May-29-23 12:02PM
May-23-23 04:05PM
May-22-23 12:53PM
11:05AM
10:06AM
07:00AM
May-19-23 02:03PM
01:57PM
May-15-23 04:44AM
May-08-23 08:23AM
Apr-24-23 07:00AM
Apr-18-23 10:07AM
07:00AM
Apr-13-23 07:00AM
Mar-06-23 08:09PM
07:00AM
Mar-03-23 06:38AM
Mar-02-23 07:00AM
Feb-27-23 07:00AM
Feb-21-23 11:14AM
Jan-18-23 07:00AM
Jan-09-23 03:34PM
08:58AM
08:00AM
Dec-18-22 06:21PM
Dec-16-22 02:24AM
Dec-15-22 09:07AM
Dec-14-22 05:00PM
Dec-12-22 03:44PM
Dec-06-22 10:07AM
Dec-05-22 07:00AM
Dec-01-22 07:00AM
Nov-23-22 07:00AM
Nov-17-22 09:07AM
07:00AM
Nov-07-22 07:00AM
Sep-29-22 07:00AM
Sep-21-22 04:30PM
Sep-19-22 10:10AM
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krishnan SumaPresident, R&DMar 11 '24Sale170.9625,0004,274,0401,550,882Mar 11 08:27 PM
Krishnan Krish SPresident and CEOMar 11 '24Sale170.9625,0004,274,0401,550,882Mar 11 08:24 PM
Krishnan SumaPresident, R&DMar 11 '24Sale170.9525,0004,273,6791,612,262Mar 11 08:27 PM
Krishnan Krish SPresident and CEOMar 11 '24Sale170.9525,0004,273,6791,612,262Mar 11 08:24 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Option Exercise63.557,500476,62514,536Mar 01 08:16 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Option Exercise31.7710,000317,75017,936Mar 01 08:20 PM
Krishnan SumaPresident, R&DFeb 28 '24Option Exercise0.0012,50001,643,047Mar 01 08:13 PM
Krishnan SumaPresident, R&DFeb 28 '24Option Exercise0.007,50001,579,353Mar 01 08:13 PM
Krishnan Krish SPresident and CEOFeb 28 '24Option Exercise0.007,50001,579,353Mar 01 08:09 PM
Krishnan Krish SPresident and CEOFeb 28 '24Option Exercise0.0012,50001,643,047Mar 01 08:09 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Sale166.057,5001,245,38112,936Mar 01 08:16 PM
ROMANO KATHRYNChief Accounting OfficerFeb 28 '24Sale165.885,000829,41712,936Mar 01 08:20 PM
ROMANO KATHRYNChief Accounting OfficerFeb 27 '24Option Exercise52.261,91399,97312,936Feb 28 09:33 PM
ROMANO KATHRYNChief Accounting OfficerFeb 26 '24Option Exercise52.268,087422,62717,556Feb 28 09:33 PM
ROMANO KATHRYNChief Accounting OfficerFeb 26 '24Sale136.918,0871,107,18012,556Feb 28 09:33 PM
Romano KathrynChief Accounting OfficerJan 22 '24Option Exercise52.262,500130,65015,056Jan 24 05:44 PM
Romano KathrynChief Accounting OfficerJan 22 '24Sale130.002,500325,00012,556Jan 24 05:44 PM
Krishnan SumaPresident, R&DDec 11 '23Sale105.6725,0002,641,6631,574,206Dec 12 05:23 PM
Krishnan Krish SPresident and CEODec 11 '23Sale105.6725,0002,641,6631,574,206Dec 12 05:17 PM
Krishnan Krish SPresident and CEODec 11 '23Sale105.6725,0002,641,6281,634,338Dec 12 05:17 PM
Krishnan SumaPresident, R&DDec 11 '23Sale105.6725,0002,641,6281,634,338Dec 12 05:23 PM
Krishnan SumaPresident, R&DSep 11 '23Sale127.2325,0003,180,8411,599,206Sep 12 06:01 PM
Krishnan Krish SPresident and CEOSep 11 '23Sale127.2325,0003,180,8411,599,206Sep 12 05:59 PM
Krishnan SumaPresident, R&DSep 11 '23Sale127.2325,0003,180,8391,659,338Sep 12 06:01 PM
Krishnan Krish SPresident and CEOSep 11 '23Sale127.2325,0003,180,8391,659,338Sep 12 05:59 PM
ORTH ANDREW C.Chief Commercial OfficerJun 09 '23Option Exercise63.5512,500794,37512,600Jun 09 07:00 PM
JANNEY DANIELDirectorJun 09 '23Sale128.7718,9352,438,223107,362Jun 09 07:03 PM
ORTH ANDREW C.Chief Commercial OfficerJun 09 '23Sale128.6112,5001,607,635100Jun 09 07:00 PM
JANNEY DANIELDirectorJun 08 '23Sale128.1131,0653,979,854126,297Jun 09 07:03 PM
Krishnan Krish SPresident and CEOMay 31 '23Sale116.2425,0002,905,9771,684,338Jun 02 06:21 PM
Krishnan SumaPresident, R&DMay 31 '23Sale116.2425,0002,905,9771,684,338Jun 02 06:23 PM
Krishnan SumaPresident, R&DMay 31 '23Sale116.1625,0002,903,9121,624,206Jun 02 06:23 PM
Krishnan Krish SPresident and CEOMay 31 '23Sale116.1625,0002,903,9121,624,206Jun 02 06:21 PM
Romano KathrynChief Accounting OfficerMay 22 '23Option Exercise57.9125,0001,447,62525,056May 23 04:23 PM
Romano KathrynChief Accounting OfficerMay 22 '23Sale109.0425,0002,725,99212,556May 23 04:23 PM
Romano KathrynChief Accounting OfficerMay 19 '23Option Exercise52.2625,0001,306,50028,484May 23 04:23 PM
JANNEY DANIELDirectorMay 19 '23Sale95.0250,0004,751,185157,362May 23 04:20 PM
Romano KathrynChief Accounting OfficerMay 19 '23Sale95.0528,4282,702,12312,556May 23 04:23 PM
JANNEY DANIELDirectorMay 09 '23Sale90.7417,1001,551,579207,362May 11 04:30 PM